Dunne et al. found that EPHA2 was a key driver of invasion and migration and a synthetically lethal target in KRASMT colorectal cancer, indicating that EPHA2 was a poor prognostic marker [50]. The gene discussed is EPHA2; the disease is colorectal cancer.